CME Group (NASDAQ:CME) PT Raised to $233.00

CME Group (NASDAQ:CME) had its price target raised by Morgan Stanley from $210.00 to $233.00 in a research note released on Thursday, Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock.

Several other research analysts also recently commented on CME. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a report on Thursday, October 3rd. Citigroup raised their target price on shares of CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Piper Sandler boosted their price target on shares of CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. Barclays increased their price target on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a report on Monday, October 7th. Finally, Oppenheimer lifted their price objective on shares of CME Group from $228.00 to $245.00 and gave the stock an “outperform” rating in a report on Monday. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $220.07.

CME Group Stock Up 0.0 %

CME opened at $227.23 on Thursday. CME Group has a twelve month low of $190.70 and a twelve month high of $230.12. The company’s 50-day moving average price is $216.48 and its two-hundred day moving average price is $208.28. The stock has a market cap of $81.82 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue was up 12.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.30 earnings per share. As a group, equities analysts expect that CME Group will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Activity

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. CVA Family Office LLC grew its position in shares of CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after buying an additional 46 shares during the last quarter. B. Riley Wealth Advisors Inc. grew its stake in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after purchasing an additional 48 shares during the period. Capital Advisors Ltd. LLC raised its holdings in CME Group by 4.3% in the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after purchasing an additional 48 shares in the last quarter. Lester Murray Antman dba SimplyRich lifted its position in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the period. Finally, Essex LLC boosted its holdings in shares of CME Group by 3.3% during the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after buying an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.